- Home
- Publications
- Publication Search
- Publication Details
Title
IL-1 Family Members in Cancer; Two Sides to Every Story
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-07
DOI
10.3389/fimmu.2019.01197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells
- (2019) Locke D. Uppendahl et al. GYNECOLOGIC ONCOLOGY
- Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer
- (2019) Oxana Dmitrieva-Posocco et al. IMMUNITY
- Role for nuclear interleukin-37 in the suppression of innate immunity
- (2019) Suzhao Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
- (2018) Kyohei Nakamura et al. CANCER CELL
- HER2 Overexpression Triggers an IL1α Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance
- (2018) Shou Liu et al. CANCER RESEARCH
- IL-1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer
- (2018) Te-Chia Wu et al. CANCER RESEARCH
- A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33
- (2018) Liang Ding et al. CARCINOGENESIS
- The enigmatic role of IL-38 in inflammatory diseases
- (2018) Thomas Garraud et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A tumor–myeloid cell axis, mediated via the cytokines IL-1α and TSLP, promotes the progression of breast cancer
- (2018) Emma L. Kuan et al. NATURE IMMUNOLOGY
- Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells
- (2018) Zhiping Yang et al. OncoTargets and Therapy
- Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases
- (2018) Graeme P. Sullivan et al. Cell Death & Disease
- IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway
- (2018) Mingfang Jiang et al. Thoracic Cancer
- An Interleukin-1 Signature in Breast Cancer Treated with Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors
- (2018) Charles Anthony Dinarello CANCER RESEARCH
- Interleukin-1 Beta—A Friend or Foe in Malignancies?
- (2018) Rebekka Bent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of IL-33/ST2 Pathway in Tumorigenesis
- (2018) Kristen Larsen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2
- (2018) Yongkui Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization
- (2018) Zafira Castaño et al. NATURE CELL BIOLOGY
- Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
- (2018) Hiroaki Takatori et al. Frontiers in Immunology
- Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer
- (2018) Aliyah M. Weinstein et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis
- (2018) Yichao Chen et al. Nanomedicine-Nanotechnology Biology and Medicine
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression
- (2018) Feng Wang et al. Open Biology
- Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer
- (2018) Razelle Kurzrock et al. OncoImmunology
- IL-1 and IL-1 regulatory pathways in cancer progression and therapy
- (2017) Alberto Mantovani et al. IMMUNOLOGICAL REVIEWS
- Biology of IL-38 and its role in disease
- (2017) Frank L. van de Veerdonk et al. IMMUNOLOGICAL REVIEWS
- Regulation and function of interleukin-36 cytokines
- (2017) Esen Yonca Bassoy et al. IMMUNOLOGICAL REVIEWS
- Suppression of inflammation and acquired immunity by IL-37
- (2017) Giulio Cavalli et al. IMMUNOLOGICAL REVIEWS
- S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
- (2017) Benjamin Weichand et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation
- (2017) Y Li et al. ONCOGENE
- Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells
- (2017) C Luo et al. ONCOGENE
- Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression
- (2017) Kazuki Takada et al. PLoS One
- Cancer cells induce interleukin-22 production from memory CD4+T cells via interleukin-1 to promote tumor growth
- (2017) Cornelia Voigt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wounds that heal and wounds that don’t − The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis
- (2017) Neal L. Millar et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- IL-36α suppresses proliferation of ovarian cancer cells
- (2017) Lei Chang et al. TUMOR BIOLOGY
- Propiece IL-1α facilitates the growth of acute T-lymphocytic leukemia cells through the activation of NF-κB and SP1
- (2017) Yinsheng Zhang et al. Oncotarget
- Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression
- (2017) Xiaofei Yan et al. Oncotarget
- The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
- (2017) Marie-Hélène Wasmer et al. Frontiers in Immunology
- The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis
- (2017) Maryse Dagenais et al. OncoImmunology
- IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
- (2017) Valeria Lucarini et al. OncoImmunology
- Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment
- (2017) Aliyah M. Weinstein et al. OncoImmunology
- Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients
- (2016) Junwei Huo et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- IL-33 signaling fuels outgrowth and metastasis of human lung cancer
- (2016) Chunhong Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells
- (2016) Keunhee Oh et al. BMC CANCER
- Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells
- (2016) M S Islam et al. BRITISH JOURNAL OF PHARMACOLOGY
- Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
- (2016) Donye Dominguez et al. JOURNAL OF IMMUNOLOGY
- Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
- (2016) Erin A. Marshall et al. Molecular Cancer
- CCL22 and IL-37 inhibit the proliferation and epithelial-mesenchymal transition process of NSCLC A549 cells
- (2016) Yu-Hua Chen et al. ONCOLOGY REPORTS
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses
- (2016) Javier Mora et al. Journal of Molecular Cell Biology
- Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer
- (2016) M Akimoto et al. Cell Death & Disease
- Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
- (2016) Miho Akimoto et al. Nature Communications
- IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling
- (2016) Rui Liu et al. Oncotarget
- Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia
- (2016) Lei Qin et al. Oncotarget
- Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma
- (2016) Lin Lin et al. Scientific Reports
- Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
- (2016) Catherine Sautès-Fridman et al. Frontiers in Immunology
- Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
- (2016) Iryna Saranchova et al. Scientific Reports
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- IL-37 Is a Novel Proangiogenic Factor of Developmental and Pathological AngiogenesisSignificance
- (2015) Tianshu Yang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway
- (2015) Yoolhee Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
- (2015) Charlotte O'Donnell et al. BRITISH JOURNAL OF CANCER
- IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses
- (2015) Xuefeng Wang et al. CANCER CELL
- The Association of Serum IL-33 and sST2 with Breast Cancer
- (2015) Zhi-Ping Yang et al. DISEASE MARKERS
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions
- (2015) Cem Gabay et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Circulating IL-33 level is associated with the progression of lung cancer
- (2015) Myung Shin Kim et al. LUNG CANCER
- IL-37 mediates the antitumor activity in renal cell carcinoma
- (2015) Yazhuo Jiang et al. MEDICAL ONCOLOGY
- Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
- (2015) Xiaoguang Tong et al. Molecular Oncology
- IL-33 activates tumor stroma to promote intestinal polyposis
- (2015) Rebecca L. Maywald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8
- (2015) Suzhao Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma
- (2015) Xavier León et al. Oncotarget
- Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells
- (2015) Sen Wang et al. Journal of Cancer
- Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
- (2015) Ole Audun Werner Haabeth et al. OncoImmunology
- Interleukin 1α Sustains the Expression of Inflammatory Factors in Human Pancreatic Cancer Microenvironment by Targeting Cancer-Associated Fibroblasts
- (2015) Vegard Tjomsland et al. NEOPLASIA
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- IL-18 Enhances Immunosuppressive Responses by Promoting Differentiation into Monocytic Myeloid-Derived Suppressor Cells
- (2014) Hui Xuan Lim et al. JOURNAL OF IMMUNOLOGY
- Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
- (2014) Marina Fabbi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
- (2014) David S Hong et al. LANCET ONCOLOGY
- Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ
- (2014) Lei Wang et al. MEDICAL ONCOLOGY
- Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages
- (2014) Kosuke Watari et al. PLoS One
- Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells
- (2014) Jing-Jing Zhao et al. Scientific Reports
- Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma
- (2013) Qiu-Zhong Pan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
- (2013) Kun Gao et al. CANCER LETTERS
- Risk of Ovarian Cancer and the NF- B Pathway: Genetic Association with IL1A and TNFSF10
- (2013) B. Charbonneau et al. CANCER RESEARCH
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of IL-1 in the Early Tumor Cell-Induced Angiogenic Response
- (2013) Y. Carmi et al. JOURNAL OF IMMUNOLOGY
- A Dose-Escalation Study of Recombinant Human Interleukin-18 in Combination With Rituximab in Patients With Non-Hodgkin Lymphoma
- (2013) Michael J. Robertson et al. JOURNAL OF IMMUNOTHERAPY
- IL-18 Regulates Melanoma VLA-4 Integrin Activation through a Hierarchized Sequence of Inflammatory Factors
- (2013) María Valcárcel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
- (2013) Su-Feng Chen et al. JOURNAL OF PATHOLOGY
- A Role for Interleukin-1 Alpha in the 1,25 Dihydroxyvitamin D3 Response in Mammary Epithelial Cells
- (2013) Sophia L. Maund et al. PLoS One
- Interleukin-1α
- (2013) Peleg Rider et al. SEMINARS IN IMMUNOLOGY
- Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
- (2012) Caterina Musolino et al. BRITISH JOURNAL OF HAEMATOLOGY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells
- (2012) M. Terme et al. CANCER RESEARCH
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
- (2012) Jing Ni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
- (2012) Yijing Li et al. Molecular Cancer
- IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
- (2012) F. L. van de Veerdonk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Interleukin-1 Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells
- (2011) S. L. Maund et al. CANCER RESEARCH
- IL-18 Induces PD-1-Dependent Immunosuppression in Cancer
- (2011) M. Terme et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
- (2011) Ivan Jovanovic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
- (2011) I-K Choi et al. GENE THERAPY
- Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis
- (2011) J Gillibert-Duplantier et al. ONCOGENE
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
- (2011) Ole Audun Werner Haabeth et al. Nature Communications
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer cell-derived IL-1α promotes HGF secretion by stromal cells and enhances metastatic potential in pancreatic cancer cells
- (2010) Donghui Xu et al. JOURNAL OF SURGICAL ONCOLOGY
- IL-37 is a fundamental inhibitor of innate immunity
- (2010) Marcel F Nold et al. NATURE IMMUNOLOGY
- Interleukin-1 (IL-1) Pathway
- (2010) A. Weber et al. Science Signaling
- A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
- (2009) Ahmad A. Tarhini et al. CANCER
- Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44
- (2009) J. S. Kang et al. CARCINOGENESIS
- Expression of ADAM33 Is a Novel Regulatory Mechanism in IL-18-Secreted Process in Gastric Cancer
- (2009) K.-E. Kim et al. JOURNAL OF IMMUNOLOGY
- Host-Derived Interleukin-1 Is Important in Determining the Immunogenicity of 3-Methylcholantrene Tumor Cells
- (2009) M. Elkabets et al. JOURNAL OF IMMUNOLOGY
- IL-18 Paradox in Pancreatic Carcinoma: Elevated Serum Levels of Free IL-18 are Correlated With Poor Survival
- (2009) Anna Carbone et al. JOURNAL OF IMMUNOTHERAPY
- Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
- (2009) John A. Lust et al. MAYO CLINIC PROCEEDINGS
- Secreted Interleukin-1 Induces a Metastatic Phenotype in Pancreatic Cancer by Sustaining a Constitutive Activation of Nuclear Factor- B
- (2009) D. Melisi et al. MOLECULAR CANCER RESEARCH
- IL-18-producing Salmonella inhibit tumor growth
- (2008) M Loeffler et al. CANCER GENE THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More